John Tsai
Pfizer (United States)(US)
Publications by Year
Research Areas
Lipoproteins and Cardiovascular Health, Health Systems, Economic Evaluations, Quality of Life, Pharmaceutical Economics and Policy, Diabetes, Cardiovascular Risks, and Lipoproteins, Cervical Cancer and HPV Research
Most-Cited Works
- → Statin Therapy, LDL Cholesterol, C-Reactive Protein, and Coronary Artery Disease(2005)1,330 cited
- → Comparative Safety of Atorvastatin 80 mg Versus 10 mg Derived from Analysis of 49 Completed Trials in 14,236 Patients(2005)160 cited
- Clinical study of 381 postmenopausal bleeding patients.(1993)
- Comparative safety of atorvastatin 80mg vs 10mg derived from analysis of 49 completed trials(2005)